A detailed history of Invesco Ltd. transactions in Si Bone, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 750,457 shares of SIBN stock, worth $9.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
750,457
Previous 29,775 2420.43%
Holding current value
$9.7 Million
Previous $624,000 1868.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$15.15 - $21.58 $10.9 Million - $15.6 Million
720,682 Added 2420.43%
750,457 $12.3 Million
Q4 2023

Feb 12, 2024

SELL
$15.75 - $21.38 $55,203 - $74,936
-3,505 Reduced 10.53%
29,775 $624,000
Q3 2023

Nov 13, 2023

SELL
$20.22 - $27.36 $2.46 Million - $3.34 Million
-121,901 Reduced 78.55%
33,280 $706,000
Q2 2023

Aug 11, 2023

BUY
$19.39 - $28.9 $2.7 Million - $4.03 Million
139,337 Added 879.43%
155,181 $4.19 Million
Q1 2023

May 12, 2023

BUY
$12.71 - $21.17 $2,783 - $4,636
219 Added 1.4%
15,844 $311,000
Q4 2022

Feb 13, 2023

BUY
$11.23 - $19.44 $5,996 - $10,380
534 Added 3.54%
15,625 $212,000
Q3 2022

Nov 14, 2022

BUY
$12.2 - $18.71 $21,411 - $32,836
1,755 Added 13.16%
15,091 $263,000
Q2 2022

Aug 15, 2022

BUY
$12.05 - $22.74 $216 - $409
18 Added 0.14%
13,336 $177,000
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $4,964 - $6,241
-271 Reduced 1.99%
13,318 $301,000
Q4 2021

Feb 14, 2022

SELL
$18.75 - $24.8 $40,181 - $53,146
-2,143 Reduced 13.62%
13,589 $303,000
Q3 2021

Nov 15, 2021

SELL
$19.65 - $31.89 $2.23 Million - $3.62 Million
-113,654 Reduced 87.84%
15,732 $337,000
Q2 2021

Aug 17, 2021

BUY
$29.4 - $35.96 $3.6 Million - $4.4 Million
122,333 Added 1734.48%
129,386 $4.07 Million
Q1 2021

May 17, 2021

BUY
$28.09 - $34.02 $198,118 - $239,943
7,053 New
7,053 $224,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $444M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.